Anti-TNF antibodies, compositions, methods and uses
US7815909B2 · kind B2 · utility
8Cited by
39References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 13, 2008 |
| Grant date | Oct 19, 2010 |
| Priority date | — |
| Expiry date | Nov 13, 2028 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A90/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to inhibiting TNF in patients having rheumatoid arthritis, psoriatic arthritis or ankylosing spondilitis, by administering anti-TNF antibodies comprising the heavy chain variable region of SEQ ID NO: 7 and the light chain variable region of SEQ ID NO:8, specific for at least one human tumor necrosis factor alpha (TNF) protein or fragment thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.